Global Chickenpox Vaccine Market Research Report 2021
SKU ID :QYR-19325700 | Published Date: 13-Oct-2021 | No. of pages: 106Description
TOC
1 Chickenpox Vaccine Market Overview
1.1 Product Overview and Scope of Chickenpox Vaccine
1.2 Chickenpox Vaccine Segment by Type
1.2.1 Global Chickenpox Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Chickenpox Vaccine Segment by Application
1.3.1 Global Chickenpox Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Chickenpox Vaccine Market Size Estimates and Forecasts
1.4.1 Global Chickenpox Vaccine Revenue 2016-2027
1.4.2 Global Chickenpox Vaccine Sales 2016-2027
1.4.3 Chickenpox Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Chickenpox Vaccine Market Competition by Manufacturers
2.1 Global Chickenpox Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Chickenpox Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Chickenpox Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Chickenpox Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Chickenpox Vaccine Market Competitive Situation and Trends
2.5.1 Chickenpox Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chickenpox Vaccine Players Market Share by Revenue
2.5.3 Global Chickenpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chickenpox Vaccine Retrospective Market Scenario by Region
3.1 Global Chickenpox Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Chickenpox Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Chickenpox Vaccine Market Facts & Figures by Country
3.3.1 North America Chickenpox Vaccine Sales by Country
3.3.2 North America Chickenpox Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chickenpox Vaccine Market Facts & Figures by Country
3.4.1 Europe Chickenpox Vaccine Sales by Country
3.4.2 Europe Chickenpox Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chickenpox Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Chickenpox Vaccine Sales by Region
3.5.2 Asia Pacific Chickenpox Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chickenpox Vaccine Market Facts & Figures by Country
3.6.1 Latin America Chickenpox Vaccine Sales by Country
3.6.2 Latin America Chickenpox Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chickenpox Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Chickenpox Vaccine Sales by Country
3.7.2 Middle East and Africa Chickenpox Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Chickenpox Vaccine Historic Market Analysis by Type
4.1 Global Chickenpox Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Chickenpox Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Chickenpox Vaccine Price by Type (2016-2021)
5 Global Chickenpox Vaccine Historic Market Analysis by Application
5.1 Global Chickenpox Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Chickenpox Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Chickenpox Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Chickenpox Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Chickenpox Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Shanghai Institute
6.3.1 Shanghai Institute Corporation Information
6.3.2 Shanghai Institute Description and Business Overview
6.3.3 Shanghai Institute Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shanghai Institute Chickenpox Vaccine Product Portfolio
6.3.5 Shanghai Institute Recent Developments/Updates
6.4 BCHT
6.4.1 BCHT Corporation Information
6.4.2 BCHT Description and Business Overview
6.4.3 BCHT Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BCHT Chickenpox Vaccine Product Portfolio
6.4.5 BCHT Recent Developments/Updates
6.5 Changsheng
6.5.1 Changsheng Corporation Information
6.5.2 Changsheng Description and Business Overview
6.5.3 Changsheng Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Changsheng Chickenpox Vaccine Product Portfolio
6.5.5 Changsheng Recent Developments/Updates
6.6 Keygen
6.6.1 Keygen Corporation Information
6.6.2 Keygen Description and Business Overview
6.6.3 Keygen Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Keygen Chickenpox Vaccine Product Portfolio
6.6.5 Keygen Recent Developments/Updates
6.7 Green Cross
6.6.1 Green Cross Corporation Information
6.6.2 Green Cross Description and Business Overview
6.6.3 Green Cross Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Green Cross Chickenpox Vaccine Product Portfolio
6.7.5 Green Cross Recent Developments/Updates
6.8 Biken
6.8.1 Biken Corporation Information
6.8.2 Biken Description and Business Overview
6.8.3 Biken Chickenpox Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biken Chickenpox Vaccine Product Portfolio
6.8.5 Biken Recent Developments/Updates
7 Chickenpox Vaccine Manufacturing Cost Analysis
7.1 Chickenpox Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chickenpox Vaccine
7.4 Chickenpox Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chickenpox Vaccine Distributors List
8.3 Chickenpox Vaccine Customers
9 Chickenpox Vaccine Market Dynamics
9.1 Chickenpox Vaccine Industry Trends
9.2 Chickenpox Vaccine Growth Drivers
9.3 Chickenpox Vaccine Market Challenges
9.4 Chickenpox Vaccine Market Restraints
10 Global Market Forecast
10.1 Chickenpox Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chickenpox Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Chickenpox Vaccine by Type (2022-2027)
10.2 Chickenpox Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chickenpox Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Chickenpox Vaccine by Application (2022-2027)
10.3 Chickenpox Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chickenpox Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Chickenpox Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Tables & Figures
List of Tables
Table 1. Global Chickenpox Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Chickenpox Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Chickenpox Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Chickenpox Vaccine Covered in This Study
Table 5. Global Chickenpox Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Chickenpox Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Chickenpox Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Chickenpox Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Chickenpox Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Chickenpox Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Chickenpox Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chickenpox Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chickenpox Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chickenpox Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global Chickenpox Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Chickenpox Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Chickenpox Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America Chickenpox Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Chickenpox Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Chickenpox Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Chickenpox Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Chickenpox Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Chickenpox Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Chickenpox Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Chickenpox Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Chickenpox Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Chickenpox Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Chickenpox Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Chickenpox Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Chickenpox Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Chickenpox Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Chickenpox Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Chickenpox Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Chickenpox Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Chickenpox Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Chickenpox Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Chickenpox Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global Chickenpox Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Chickenpox Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Chickenpox Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Chickenpox Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Chickenpox Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global Chickenpox Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Chickenpox Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Chickenpox Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Chickenpox Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Merck Chickenpox Vaccine Product
Table 52. Merck Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. GSK Chickenpox Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Shanghai Institute Corporation Information
Table 59. Shanghai Institute Description and Business Overview
Table 60. Shanghai Institute Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Shanghai Institute Chickenpox Vaccine Product
Table 62. Shanghai Institute Recent Developments/Updates
Table 63. BCHT Corporation Information
Table 64. BCHT Description and Business Overview
Table 65. BCHT Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. BCHT Chickenpox Vaccine Product
Table 67. BCHT Recent Developments/Updates
Table 68. Changsheng Corporation Information
Table 69. Changsheng Description and Business Overview
Table 70. Changsheng Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Changsheng Chickenpox Vaccine Product
Table 72. Changsheng Recent Developments/Updates
Table 73. Keygen Corporation Information
Table 74. Keygen Description and Business Overview
Table 75. Keygen Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Keygen Chickenpox Vaccine Product
Table 77. Keygen Recent Developments/Updates
Table 78. Green Cross Corporation Information
Table 79. Green Cross Description and Business Overview
Table 80. Green Cross Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Green Cross Chickenpox Vaccine Product
Table 82. Green Cross Recent Developments/Updates
Table 83. Biken Corporation Information
Table 84. Biken Description and Business Overview
Table 85. Biken Chickenpox Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Biken Chickenpox Vaccine Product
Table 87. Biken Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Chickenpox Vaccine Distributors List
Table 91. Chickenpox Vaccine Customers List
Table 92. Chickenpox Vaccine Market Trends
Table 93. Chickenpox Vaccine Growth Drivers
Table 94. Chickenpox Vaccine Market Challenges
Table 95. Chickenpox Vaccine Market Restraints
Table 96. Global Chickenpox Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 97. Global Chickenpox Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Chickenpox Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Chickenpox Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Chickenpox Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 101. Global Chickenpox Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Chickenpox Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Chickenpox Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Chickenpox Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 105. Global Chickenpox Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Chickenpox Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Chickenpox Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chickenpox Vaccine
Figure 2. Global Chickenpox Vaccine Market Share by Type in 2020 & 2027
Figure 3. Monovalent Vaccine Product Picture
Figure 4. Combination Vaccine Product Picture
Figure 5. Global Chickenpox Vaccine Market Share by Application in 2020 & 2027
Figure 6. Kids Injection
Figure 7. Adults Injection
Figure 8. Global Chickenpox Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Chickenpox Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Chickenpox Vaccine Sales 2016-2027 (K Doses)
Figure 11. Global Chickenpox Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Chickenpox Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Chickenpox Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Chickenpox Vaccine Players: Market Share by Revenue in 2020
Figure 15. Chickenpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Chickenpox Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Chickenpox Vaccine Sales Market Share by Region in 2020
Figure 18. Global Chickenpox Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Chickenpox Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Chickenpox Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Chickenpox Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Chickenpox Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Chickenpox Vaccine by Application in 2020
Figure 47. Revenue Share of Chickenpox Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Chickenpox Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Chickenpox Vaccine
Figure 50. Manufacturing Process Analysis of Chickenpox Vaccine
Figure 51. Chickenpox Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Companies
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
- PRICE
-
$2900$5800$4350Buy Now